Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Byres

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Nursing Leadership (Toronto, Ont.)|April 21, 2018
Public Policy and Canadian Nursing: Lessons from the Field By Michael J. VilleneuveLynn Stevenson, David Byres
Nursing Leadership (Toronto, Ont.)|October 24, 2020
Letter to the EditorDavid Byres, Natasha Prodan-Bhalla, R Lynn Stevenson
International Journal of Health Services : Planning, Administration, Evaluation|January 31, 2022
Through An Equity Lens: Illuminating The Relationships Among Social Inequities, Stigma And Discrimination, And Patient Experiences of Emergency Health CareColleen Varcoe, Annette J Browne, Vicky Bungay, et al.
Journal of Substance Use and Addiction Treatment|August 31, 2023
The mobilization of nurse-client therapeutic relationships in injectable opioid agonist treatment: Autonomy, advocacy and actionSarin Blawatt, Scott Harrison, David Byres, et al.
Substance Abuse Treatment, Prevention, and Policy|September 30, 2023
The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic reviewAlison Adams, Sarin Blawatt, Tianna Magel, et al.
The International Journal on Drug Policy|May 14, 2023
Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic reviewAlison Adams, Sarin Blawatt, Scott MacDonald, et al.
Harm Reduction Journal|April 14, 2023
"As long as that place stays open, I'll stay alive": Accessing injectable opioid agonist treatment during dual public health crisesKaitlyn Jaffe, Sarin Blawatt, Eisha Lehal, et al.
BMC Health Services Research|September 1, 2022
EQUIP emergency: can interventions to reduce racism, discrimination and stigma in EDs improve outcomes?Colleen Varcoe, Annette J Browne, Nancy Perrin, et al.
The International Journal on Drug Policy|December 31, 2022
Measuring the preferences of injectable opioid agonist treatment (iOAT) clients: Development of a person-centered scale (best-worst scaling)Sophia Dobischok, Rebecca Metcalfe, Elizabeth Matzinger, et al.
Healthcare Management Forum|July 20, 2024
Shaping the future of healthcare in British Columbia: Establishing provincial clinical governance for responsible deployment of artificial intelligence toolsAngel Arnaout, Prabjot Gill, Alice Virani, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Nursing Leadership (Toronto, Ont.)|April 21, 2018
Public Policy and Canadian Nursing: Lessons from the Field By Michael J. VilleneuveLynn Stevenson, David Byres
Nursing Leadership (Toronto, Ont.)|October 24, 2020
Letter to the EditorDavid Byres, Natasha Prodan-Bhalla, R Lynn Stevenson
International Journal of Health Services : Planning, Administration, Evaluation|January 31, 2022
Through An Equity Lens: Illuminating The Relationships Among Social Inequities, Stigma And Discrimination, And Patient Experiences of Emergency Health CareColleen Varcoe, Annette J Browne, Vicky Bungay, et al.
Journal of Substance Use and Addiction Treatment|August 31, 2023
The mobilization of nurse-client therapeutic relationships in injectable opioid agonist treatment: Autonomy, advocacy and actionSarin Blawatt, Scott Harrison, David Byres, et al.
Substance Abuse Treatment, Prevention, and Policy|September 30, 2023
The impact of relaxing restrictions on take-home doses during the COVID-19 pandemic on program effectiveness and client experiences in opioid agonist treatment: a mixed methods systematic reviewAlison Adams, Sarin Blawatt, Tianna Magel, et al.
The International Journal on Drug Policy|May 14, 2023
Provider experiences with relaxing restrictions on take-home medications for opioid use disorder during the COVID-19 pandemic: A qualitative systematic reviewAlison Adams, Sarin Blawatt, Scott MacDonald, et al.
Harm Reduction Journal|April 14, 2023
"As long as that place stays open, I'll stay alive": Accessing injectable opioid agonist treatment during dual public health crisesKaitlyn Jaffe, Sarin Blawatt, Eisha Lehal, et al.
BMC Health Services Research|September 1, 2022
EQUIP emergency: can interventions to reduce racism, discrimination and stigma in EDs improve outcomes?Colleen Varcoe, Annette J Browne, Nancy Perrin, et al.
The International Journal on Drug Policy|December 31, 2022
Measuring the preferences of injectable opioid agonist treatment (iOAT) clients: Development of a person-centered scale (best-worst scaling)Sophia Dobischok, Rebecca Metcalfe, Elizabeth Matzinger, et al.
Healthcare Management Forum|July 20, 2024
Shaping the future of healthcare in British Columbia: Establishing provincial clinical governance for responsible deployment of artificial intelligence toolsAngel Arnaout, Prabjot Gill, Alice Virani, et al.
Pageof 2